Getinge has acquired 100 percent of the shares in US-based Healthmark Industries Co. Inc., a provider of instrument care and infection control consumables, for approximately 320 million USD.

This strategic step enhances Getinge’s presence within sterile reprocessing in the US and facilitates a global expansion for Healthmark, it states.

“We are excited and honored to team up with Healthmark,” says Stéphane Le Roy, President Surgical Workflows at Getinge. “Together we will offer a broad range of solutions to sterile processing departments in hospitals. Healthmark’s position in the field of consumables for cleaning verification and packaging will be an ideal complement to our consumables, reprocessing capital equipment, and software solutions. The acquisition strengthens Getinge’s position in the infection prevention sector in the US, and our global customer reach in Europe and Asia will also accelerate Healthmark’s international development.”

Healthmark Industries

Founded in 1969, Healthmark’s headquarters and main production facilities are located in Fraser, Michigan in the United States. Healthmark also has a facility in Bobigny, France. Globally, Healthmark employs approximately 400 employees. In its fiscal year ending October 31, 2023, Healthmark expects nearly USD 126 million in net sales, an approximate 15% increase over fiscal year 2022, which will translate into a material contribution to the net revenue and EBITDA of Getinge’s Surgical Workflows business area. Approximately 90% of Healthmark’s sales originate from the United States.

The acquisition has been financed through cash on hand and existing credit facilities. Getinge expects to have fully integrated Healthmark by the end of 2024 and anticipates no material integration costs in 2023 and 2024.

Photo of Stephane Le Roy: Emelie Asplund/Getinge